Top compounds associated with response to RTEL1-TNFRSF6B


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.06
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.064 0.07
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.069 0.07
mRNA CIL55A CTRPv2 pan-cancer AAC 0.095 0.07
mRNA barasertib CTRPv2 pan-cancer AAC -0.06 0.07
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.1 0.07
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.062 0.07
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.071 0.07
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.084 0.07
Download CSV